AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,672,714 | $63,128,000 | 30.14% |
| Foresite Capital Management III, LLC | 1,697,884 | $64,078,000 | 29.95% |
| Asymmetry Capital Management, L.P. | 150,651 | $5,686,000 | 9.89% |
| ACUTA CAPITAL PARTNERS, LLC | 280,000 | $10,567,000 | 3.97% |
| Avoro Capital Advisors LLC | 500,000 | $18,870,000 | 3.31% |
| Convector Capital Management, LP | 38,444 | $1,451,000 | 2.66% |
| DAFNA Capital Management LLC | 91,869 | $3,467,000 | 2.42% |
| Partner Investment Management, L.P. | 42,438 | $1,602,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,338,829 | $50,527,000 | 2.35% |
| Iguana Healthcare Management, LLC | 330,000 | $12,454,000 | 2.22% |